Gujarat Terce Laboratories Limited (BOM:524314)
India · Delayed Price · Currency is INR 40.75
-0.51 (-1.24%)
At close: Aug 29, 2025
BOM:524314 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 501.95 | 479.75 | 467.83 | 401.34 | 251.78 | Upgrade | |
Revenue Growth (YoY) | 4.63% | 2.55% | 16.57% | 59.40% | -32.94% | Upgrade |
Cost of Revenue | 191.63 | 177.53 | 193.8 | 154.49 | 100.54 | Upgrade |
Gross Profit | 310.32 | 302.22 | 274.02 | 246.85 | 151.24 | Upgrade |
Selling, General & Admin | 195.01 | 190.32 | 175.62 | 182.22 | 142.29 | Upgrade |
Other Operating Expenses | 76.49 | 99.23 | 120 | 53.45 | 34.84 | Upgrade |
Operating Expenses | 275.34 | 293.23 | 299.26 | 238.43 | 178.9 | Upgrade |
Operating Income | 34.98 | 8.99 | -25.24 | 8.42 | -27.66 | Upgrade |
Interest Expense | -3.62 | -6.28 | -6.68 | -3.33 | -3.44 | Upgrade |
Interest & Investment Income | 2.56 | 3.03 | 3.55 | 2.88 | 3.02 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | 0.01 | Upgrade |
Other Non Operating Income (Expenses) | -0.13 | -0.3 | -0.53 | -0.68 | -0.47 | Upgrade |
EBT Excluding Unusual Items | 33.79 | 5.44 | -28.9 | 7.28 | -28.54 | Upgrade |
Gain (Loss) on Sale of Investments | 0.11 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -0.04 | - | -1.78 | Upgrade |
Pretax Income | 33.9 | 5.44 | -28.94 | 7.47 | -25.32 | Upgrade |
Income Tax Expense | 43.69 | 3.01 | -12.22 | -1.26 | -0.11 | Upgrade |
Net Income | -9.79 | 2.44 | -16.72 | 8.72 | -25.2 | Upgrade |
Net Income to Common | -9.79 | 2.44 | -16.72 | 8.72 | -25.2 | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | Upgrade |
EPS (Basic) | -1.32 | 0.33 | -2.25 | 1.18 | -3.40 | Upgrade |
EPS (Diluted) | -1.32 | 0.33 | -2.25 | 1.18 | -3.40 | Upgrade |
Free Cash Flow | 30.59 | 25.26 | -0.36 | -25.57 | -6.68 | Upgrade |
Free Cash Flow Per Share | 4.12 | 3.40 | -0.05 | -3.45 | -0.90 | Upgrade |
Gross Margin | 61.82% | 63.00% | 58.57% | 61.51% | 60.07% | Upgrade |
Operating Margin | 6.97% | 1.87% | -5.39% | 2.10% | -10.99% | Upgrade |
Profit Margin | -1.95% | 0.51% | -3.57% | 2.17% | -10.01% | Upgrade |
Free Cash Flow Margin | 6.09% | 5.27% | -0.08% | -6.37% | -2.65% | Upgrade |
EBITDA | 38.83 | 12.67 | -21.59 | 11.18 | -25.9 | Upgrade |
EBITDA Margin | 7.74% | 2.64% | -4.61% | 2.78% | -10.29% | Upgrade |
D&A For EBITDA | 3.85 | 3.68 | 3.65 | 2.76 | 1.76 | Upgrade |
EBIT | 34.98 | 8.99 | -25.24 | 8.42 | -27.66 | Upgrade |
EBIT Margin | 6.97% | 1.87% | -5.39% | 2.10% | -10.99% | Upgrade |
Effective Tax Rate | 128.87% | 55.24% | - | - | - | Upgrade |
Revenue as Reported | 505.03 | 482.96 | 471.37 | 404.4 | 259.8 | Upgrade |
Advertising Expenses | 31.18 | 30.1 | 25.85 | 21.85 | 10.94 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.